« Back to Record
Citation APA

Lambertini, M., Ceppi, M., Anderson, R. A., Cameron, D. A., Bruzzone, M., Franzoi, M. A., Massarotti, C., El-Abed, S., Wang, Y., Lecocq, C., Nuciforo, P., Rolyance, R., Pusztai, L., Sohn, J., Latocca, M. M., Arecco, L., Pistilli, B., Ruddy, K. J., Ballestrero, A., Del Mastro, L., Peccatori, F. A., Partridge, A. H., Saura, C., Untch, M., Piccart, M., Di Cosimo, S., de Azambuja, E., & Demeestere, I. (2023). Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer. Journal of the National Comprehensive Cancer Network, 21(1), 33-41.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/356790

Lambertini, M., Ceppi, M., Anderson, R. A., Cameron, D. A., Bruzzone, M., Franzoi, M. A., Massarotti, C., El-Abed, S., Wang, Y., Lecocq, C., Nuciforo, P., Rolyance, R., Pusztai, L., Sohn, J., Latocca, M. M., Arecco, L., Pistilli, B., Ruddy, K. J., Ballestrero, A., Del Mastro, L., Peccatori, F. A., Partridge, A. H., Saura, C., Untch, M., Piccart, M., Di Cosimo, S., de Azambuja, E., & Demeestere, I. (2023). Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer. Journal of the National Comprehensive Cancer Network, 21(1), 33-41.